AzTrials
AzTrials

Acute Mesenteric IschemiaAMI_HMARNCT06310395

Analysis of the Acute Mesenteric Ischemia in a Single Institution Over 10 Years

An observational study of Acute Mesenteric Ischemia, run by Hospital del Mar.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Acute mesenteric ischemia (AMI) is a notorious disease with a high mortality, the diagnostic and management is truly multidisciplinary, but it is not the reality in many Hospitals. The aim of this study is to analyse the results of the patients admitted with an AMI in Hospital de Mar. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Acute Mesenteric Ischemia
How many people
100 participants
Where
No sites listed yet
Study dates
15 Jun 2024to 15 Oct 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All patients admited in Hospital del Mar from 2014 to 2023 with a diagnostic of AMI

Who may be able to join

  • Acute Mesenteric Ischemia

Who cannot join

  • Chronic Mesenteric Ischemia
  • Ischemic Colitis
  • Bowel obstruction strangulation
  • Inflamatory bowel necrosis

About this study

Official title: Analysis of the Acute Mesenteric Ischemia Management in a Single Institution Over 10 Years

Acute mesenteric ischemia (AMI) is a notorious disease with a high mortality, the diagnostic and management is truly multidisciplinary, but it is not the reality in many Hospitals.

The aim of this study is to analyse the results of the patients admitted with an AMI in Hospital de Mar.

Read the detailed description

Acute mesenteric ischemia (AMI) is a notorious disease with a high mortality from 50 to 80%. Even though AMI is a relatively rare condition (1:1,000) the incidence rises exponentially with increasing age, in patients older than 75 years, the incidence of AMI has been reported higher than that of acute appendicitis. AMI patients benefit from early assessment in a surgical unit with capabilities to definitive management. The diagnosis and management of AMI are truly multidisciplinary, requiring high index of suspicion and awareness from emergency department physicians, preferably computed tomography angiography with precise interpretation.

The aim of this study is to analyse the results of the patients admitted with an AMI in Hospital de Mar from January 2014 to December 2023.

Keywords
Mesenteric ischemia, Acute Mesenteric ischemia, Abdominal pain, Elderly, Complications, Mortality
Medical subject headings
Mesenteric Ischemia, Abdominal Pain

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mortality

    To describe the mortality in patients with a diagnostic of AMI

    Measured: 2014-2023

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Mar 2024
  2. Study start15 Jun 2024 (estimated)
  3. Primary completion15 Jul 2024 (estimated)
  4. Study completion15 Oct 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06310395
Sponsor's protocol ID
AMI_H.MAR
Acronym
AMI_HMAR
Status last verified
May 2024
First submitted
7 Mar 2024
Last updated
22 May 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Mesenteric Ischemia, run by Hospital del Mar.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 May 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mortality (time frame: 2014-2023). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in